I joined HIMS in 2025 as professor by special appointment in the position titled ‘Separation of Biomacromolecules, with an Emphasis on Sustainable Analytical Science’. The focus of this role is to develop next generation separation science for new modality compounds (particularly peptides and oligonucleotides) which are greener and more sustainable than current contemporary standards. Areas within scope for research are many forms of separation science (which is the highest polluter of all the analytical sciences), spectroscopy and spectrometry. Another focus area is the use of in-silico approaches to streamline method development and data reporting. This position aligns very closely with my role at AstraZeneca where I am a Principal Scientist in Global Product Development (Macclesfield, UK). I have worked in the pharmaceutical industry for over 25 years with many of my roles focussing on separation science and many different molecule types. I currently work with several HIMS colleagues (Dr. Bob Pirok, Dr Andrea Gargano and Dr Saer Samanipour) on the NWO Key Technologies funded InnovATOR project.